Merida Biosciences

Precision therapy for autoimmune-driven diseases is now within reach

Boston, United States · Founded 2024 · $121.0M raised

Headquarters
Boston
Founded
2024
Business Model
B2B
Total Funding
$121.0M
Last Round
$121.0M Series AApr 2025
Rounds
1

About

Merida Biosciences is a precision immunology company developing therapeutics for autoimmune and allergic diseases. Its novel platform aims to target and eliminate the pathogenic drivers of antibody-driven diseases with unprecedented precision and durability, addressing the root cause of disease rather than the non-specific, side-effect-prone treatments available today. Founded by Dario Gutierrez, Ph.D. with backing from Third Rock Ventures, the company launched publicly in April 2025 with $121M in Series A financing.

Summary

Merida Biosciences is a Biotech company based in Boston, United States, founded in 2024. It has raised $121.0M in total across 1 round, most recently a $121.0M Series A round in Apr 2025. Investors include Third Rock Ventures, Bain Capital Life Sciences and BVF Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2025
$121.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Merida Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/merida-biosciences"><img src="https://indexed.vc/api/badge/company/merida-biosciences" alt="Merida Biosciences on Indexed.vc" width="260" height="76" /></a>